Longitudinal patterns of new Benzodiazepine use in the elderly

Pharmacoepidemiology and Drug Safety
Gillian BartlettRoxane du Berger

Abstract

To characterize longitudinal patterns of Benzodiazepine use in the elderly. Prospective cohort of 78 367 community-dwelling Quebec residents aged 66 years or more who were new Benzodiazepine users, was followed for 5 years, 1989-1994. Data acquired from four population-based, provincial administrative databases were used to create time-dependent measures of change in dosage, switching or adding Benzodiazepines for 11 drugs listed in the provincial formulary. Subject-specific Spearman's rank correlation coefficients between dose and time were used to measure the tendency of increasing dose with consecutive periods of use. Multiple logistic regression and generalized estimating equations (GEE) models evaluated subject characteristics associated with increasing dose. The mean duration of uninterrupted Benzodiazepine use was 75.5 days. The mean daily dose was about half the recommended adult daily dose but 8.6% of subjects exceeded the recommended adult dose. Some of them (28.8%) switched medications at least once and 8.2% filled two or more prescriptions concurrently. For women, older age at date of first prescription was associated with increasing dose over time (odds ratio (OR) for 10 year age increase = 1.23, p < 0.001). Long p...Continue Reading

Citations

Feb 8, 2011·European Journal of Clinical Pharmacology·Maria RikalaSirpa Hartikainen
Apr 20, 2006·Zeitschrift für Gerontologie und Geriatrie·F Hoffmann, G Glaeske
Nov 18, 2006·Pharmacy World & Science : PWS·Sofia de Oliveira MartinsJosé Cabrita
Apr 25, 2007·Journal of General Internal Medicine·Chaim M BellPaula A Rochon
Apr 28, 2010·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Philippe VoyerSarah-Gabrielle Béland
Jul 18, 2012·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Michel PrévilleYola Moride
Feb 8, 2013·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Pamphile-Gervais Nkogho MenguePhilippe Voyer
Oct 26, 2005·Journal of Community Health Nursing·Philippe VoyerMichel Préville
Nov 19, 2013·Journal of Comparative Effectiveness Research·Raluca Ionescu-Ittu, Louise Pilote
Dec 23, 2011·European Journal of Clinical Pharmacology·Jolyce BourgeoisRobert R Vander Stichele
Apr 9, 2011·Otolaryngologic Clinics of North America·Osama A ShoairPatricia W Slattum
Nov 7, 2015·European Psychiatry : the Journal of the Association of European Psychiatrists·T A T KurkoJ Hietala
Jan 28, 2005·Journal of the American Geriatrics Society·Robyn TamblynGillian Bartlett
Aug 27, 2009·Statistics in Medicine·Marie-Pierre Sylvestre, Michal Abrahamowicz
Aug 30, 2007·Australian and New Zealand Journal of Public Health·Alice WindleVivienne Moore
Dec 20, 2008·Journal of the American Geriatrics Society·Keith R StowellMary Ganguli
Jun 2, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Meng-Ting WangAgnes L F Chan
Nov 19, 2011·Statistics in Medicine·Michal AbrahamowiczMarie-Pierre Sylvestre
Jan 15, 2010·Pharmacoepidemiology and Drug Safety·Samantha A Hollingworth, Dan J Siskind
Jul 12, 2013·The International Journal of Neuropsychopharmacology·Ramit Ravona-Springer, Michael Davidson
Mar 22, 2007·Thérapie·Vincent PradelOlivier Blin
Dec 21, 2007·São Paulo Medical Journal = Revista Paulista De Medicina·Carmen Sylvia RibeiroNeury José Botega
Sep 30, 2017·Clinical Gerontologist·Constance H FungCathy A Alessi
Aug 24, 2017·BMC Psychiatry·Soo-Hee HwangTae Hyun Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.